CL2024002678A1 - Sistema vectorial modular (modvec): una plataforma para construir vectores de expresión de nueva generación - Google Patents

Sistema vectorial modular (modvec): una plataforma para construir vectores de expresión de nueva generación

Info

Publication number
CL2024002678A1
CL2024002678A1 CL2024002678A CL2024002678A CL2024002678A1 CL 2024002678 A1 CL2024002678 A1 CL 2024002678A1 CL 2024002678 A CL2024002678 A CL 2024002678A CL 2024002678 A CL2024002678 A CL 2024002678A CL 2024002678 A1 CL2024002678 A1 CL 2024002678A1
Authority
CL
Chile
Prior art keywords
modvec
platform
chains
expression vectors
vector system
Prior art date
Application number
CL2024002678A
Other languages
English (en)
Inventor
Mock Marissa
Chen Fuyi
J Belouski Edward
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CL2024002678A1 publication Critical patent/CL2024002678A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)

Abstract

La presente invención se dirige a un método para optimizar los niveles de expresión de una proteína multicadena en el que la proteína comprende al menos dos cadenas polipeptídicas diferentes. La generación de proteínas multicadena presenta grandes retos debido al emparejamiento/plegado de nuevas estructuras cuaternarias compuestas por múltiples cadenas polipeptídicas, en particular cuando se emparejan cadenas pesadas y ligeras de anticuerpos en un formato multiespecífico. La expresión de las diferentes cadenas en la relación adecuada dentro de la célula es de vital importancia para el ensamblaje eficiente y adecuado de múltiples moléculas de cadenas polipeptídicas. La presente invención estas cuestiones.
CL2024002678A 2022-03-08 2024-09-06 Sistema vectorial modular (modvec): una plataforma para construir vectores de expresión de nueva generación CL2024002678A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202263317949P 2022-03-08 2022-03-08

Publications (1)

Publication Number Publication Date
CL2024002678A1 true CL2024002678A1 (es) 2025-02-07

Family

ID=85772065

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2024002678A CL2024002678A1 (es) 2022-03-08 2024-09-06 Sistema vectorial modular (modvec): una plataforma para construir vectores de expresión de nueva generación

Country Status (11)

Country Link
US (1) US20250188447A1 (es)
EP (1) EP4490177A1 (es)
JP (1) JP2025508002A (es)
KR (1) KR20240155957A (es)
CN (1) CN119137145A (es)
AU (1) AU2023230891A1 (es)
CA (1) CA3254041A1 (es)
CL (1) CL2024002678A1 (es)
IL (1) IL315140A (es)
MX (1) MX2024010960A (es)
WO (1) WO2023172903A1 (es)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30985A (en) 1860-12-18 Thomas l
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
ATE135397T1 (de) 1988-09-23 1996-03-15 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US10253321B2 (en) * 2013-05-01 2019-04-09 Dna2.0, Inc. Methods, compositions and kits for a one-step DNA cloning system
CN113015801A (zh) * 2018-09-20 2021-06-22 赛诺菲 基于内含子的通用克隆方法和组合物

Also Published As

Publication number Publication date
MX2024010960A (es) 2024-09-18
EP4490177A1 (en) 2025-01-15
US20250188447A1 (en) 2025-06-12
CN119137145A (zh) 2024-12-13
IL315140A (en) 2024-10-01
CA3254041A1 (en) 2023-09-14
WO2023172903A1 (en) 2023-09-14
AU2023230891A1 (en) 2024-09-12
KR20240155957A (ko) 2024-10-29
JP2025508002A (ja) 2025-03-21

Similar Documents

Publication Publication Date Title
PE20071111A1 (es) Metodos para modular el contenido de manosa de proteinas recombinantes
MX2014014801A (es) Metodo para la seleccion y produccion de entidades dirigidas altamente selectivas hechas a la medida y multiespecificas que contienen por lo menos dos entidades de union diferentes y usos de las mismas.
AR120511A2 (es) Producción de proteínas heteromultiméricas
ES2585480T3 (es) Anticuerpo anti-NR10 y uso del mismo
BR112022019428A2 (pt) Indicações precoces de atualização crítica para dispositivos multilink
CY1123774T1 (el) Στελεχη shigella me υπερφυσαλιδωση
PE20201346A1 (es) Constructos de fusion de anticuerpos que se acoplan a celulas nk
DK1685243T3 (da) Immortaliserede fuglecellelinjer til virusproduktion
MX2022011472A (es) Formato de anticuerpo multiespecifico heterodimerico.
BR112012011704A2 (pt) anticorpos multivalentes
MX344312B (es) Proteinas mirac.
WO2012064733A3 (en) Antibody scaffold for homogenous conjugation
MX2019001686A (es) Modernizacion de farola para proporcionar acceso a redes inalambricas y celulares.
RU2011102548A (ru) Оптимизация растворимости иммуносвязывающих средств
CY1117738T1 (el) Συστημα και μεθοδος κοινης χρησης γραμμης αγκυρωσης εξεδρας τυπου spar
AR094779A1 (es) Cetuximab con glicosilación modificada y sus usos
MX2021005048A (es) Anticuerpos anti-ctla4, fragmentos de anticuerpos, sus inmunoconjugados y usos.
ES2620264T3 (es) Anticuerpos humanizados frente a LIV-1 y el uso de los mismos para tratar el cáncer
BRPI0905076A2 (pt) Polipeptídeo, anticorpo, região variável, cadeia pesada ou cadeia leve, gene, vetor, célula hospedeira, método para produzir o referido polipeptídeo, e composição farmacêutica compreendendo o mesmo
MX350082B (es) Moleculas de entrega selectiva y metodos de uso.
MX2021000788A (es) Composiciones de anticuerpos del receptor de fc (fcrn).
CL2017001506A1 (es) Sistema de enlace de oruga reversible
RU2010105090A (ru) Транспортер с шагающими балками
CL2024002678A1 (es) Sistema vectorial modular (modvec): una plataforma para construir vectores de expresión de nueva generación
HRP20180155T1 (hr) Novo protutijelo protiv ljudskog ngf